Tagworks Pharmaceuticals bags $65m in Series A for Click-to-Release technology
Tagworks Pharmaceuticals BV, a Netherlands-based pioneer in Click-to-Release chemistry that promotes more effective and safer systemic therapies, has secured $65 million in Series A funding. The investment round, which saw major participation from Spanish venture capital firm Ysios Capital and Gilde Healthcare, along with Novartis Venture Fund, New Enterprise Associates (NEA), and Lightstone Ventures, will […]